Jump to content
  • Explore the aspects of Continuous Improvement

    Within the life sciences industry with our new course. Now with 20% off.

    More Information
  • Navigate a rapidly changing environment

    With our GCP Inspection course, next running 8th October.

    View Programme
  • 3rd European QA Conference 2019

    Europe's largest quality event in the industry. Join over 500 Quality professionals in Dublin this November.

    View Programme

Who are RQA

The Research Quality Association (RQA) is a professional membership body dedicated to informing and advancing its members. We provide status and visibility for individuals engaged in the quality of research concerning pharmaceuticals, agrochemicals, chemicals and medical devices. Since our inception in 1977, the Association has increased and evolved to reflect regulatory changes, the growing impact of regulatory inspection and the ever-changing structure and needs of industry. RQA's purpose is to drive quality and integrity in scientific research.  

Read more+

Our Mission

1. To develop and promote quality standards in scientific research.

2. To facilitate knowledge sharing and transfer through:

  • Discussion
  • Training
  • Seminars
  • Forums 
  • Conferences
  • Publications
  • Podcasts
  • Partnership and co-operation

3. To liaise with regulatory agencies in the development and interpretation of regulations and guidance.

Newsletter

Sign up to the latest news and events.

Latest News

View all news

Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC)

Includes agenda and Sept 2019 PRAC statistics

Read more+

MHRA: Brexit No-Deal Update

The MHRA have updated their guidelines on how you can continue to submit regulatory and notification information to the UK.

Read more+

EMA publishes first two Guidances on Drug Shortages

Regulators in the European Union have taken first steps to diminish shortages of medicinal products. The European Medicines Agency (EMA) and the Heads of Medicines Agencies (HMA) published two guidance documents which can be seen as foundation or first step for a long way: how to define and how to communicate drug shortages.

Read more+